New device aims to help stroke survivors move their arms again

NCT ID NCT06483230

Recruiting now Symptom relief Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a device called IVS3 is tolerable and easy to use for arm recovery in people who had a stroke at least 6 months ago. The device uses mirrored video to create the illusion that the affected arm is moving. Researchers will track how many sessions participants attend and any safety issues, and measure satisfaction and usability. The study involves 25 outpatients and focuses on feasibility, not yet on proving the device works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intensive Visual Stimulation (IVS3) device
What this could lead to: If successful, this could point toward a practical, non-invasive tool to help stroke survivors improve arm movement during rehab.
What could go wrong: This is a very small pilot study (25 people) focused on feasibility, not proof of effectiveness. The device may not provide meaningful motor improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIRROR MOVEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial congenital mirror movements Motor Activity myocardial infarction perceptual disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIRROR MOVEMENT MOTOR ACTIVITY NEGLECT, HEMISPATIAL STROKE, CARDIOVASCULAR

Contacts and locations

Locations

Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.